136 related articles for article (PubMed ID: 17315988)
1. Design, synthesis, and activity of 2-imidazol-1-ylpyrimidine derived inducible nitric oxide synthase dimerization inhibitors.
Davey DD; Adler M; Arnaiz D; Eagen K; Erickson S; Guilford W; Kenrick M; Morrissey MM; Ohlmeyer M; Pan G; Paradkar VM; Parkinson J; Polokoff M; Saionz K; Santos C; Subramanyam B; Vergona R; Wei RG; Whitlow M; Ye B; Zhao ZS; Devlin JJ; Phillips G
J Med Chem; 2007 Mar; 50(6):1146-57. PubMed ID: 17315988
[TBL] [Abstract][Full Text] [Related]
2. PPA250 [3-(2,4-difluorophenyl)-6-[2-[4-(1H-imidazol-1-ylmethyl) phenoxy]ethoxy]-2-phenylpyridine], a novel orally effective inhibitor of the dimerization of inducible nitric-oxide synthase, exhibits an anti-inflammatory effect in animal models of chronic arthritis.
Ohtsuka M; Konno F; Honda H; Oikawa T; Ishikawa M; Iwase N; Isomae K; Ishii F; Hemmi H; Sato S
J Pharmacol Exp Ther; 2002 Oct; 303(1):52-7. PubMed ID: 12235232
[TBL] [Abstract][Full Text] [Related]
3. 1-(1,3-Benzodioxol-5-ylmethyl)-3-[4-(1H-imidazol-1-yl)phenoxy]-piperidine analogs as potent and selective inhibitors of nitric oxide formation.
Wei RG; Adler M; Davey D; Ho E; Mohan R; Polokoff M; Tseng JL; Whitlow M; Xu W; Yuan S; Phillips G
Bioorg Med Chem Lett; 2007 May; 17(9):2499-504. PubMed ID: 17368901
[TBL] [Abstract][Full Text] [Related]
4. 2-Iminohomopiperidinium salts as selective inhibitors of inducible nitric oxide synthase (iNOS).
Hansen DW; Peterson KB; Trivedi M; Kramer SW; Webber RK; Tjoeng FS; Moore WM; Jerome GM; Kornmeier CM; Manning PT; Connor JR; Misko TP; Currie MG; Pitzele BS
J Med Chem; 1998 Apr; 41(9):1361-6. PubMed ID: 9554868
[TBL] [Abstract][Full Text] [Related]
5. Identification and SAR of selective inducible nitric oxide synthase (iNOS) dimerization inhibitors.
Gahman TC; Herbert MR; Lang H; Thayer A; Symons KT; Nguyen PM; Massari ME; Dozier S; Zhang Y; Sablad M; Rao TS; Noble SA; Shiau AK; Hassig CA
Bioorg Med Chem Lett; 2011 Nov; 21(22):6888-94. PubMed ID: 21986586
[TBL] [Abstract][Full Text] [Related]
6. The novel imidazopyridine 2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) is a highly selective inhibitor of the inducible nitric-oxide synthase.
Strub A; Ulrich WR; Hesslinger C; Eltze M; Fuchss T; Strassner J; Strand S; Lehner MD; Boer R
Mol Pharmacol; 2006 Jan; 69(1):328-37. PubMed ID: 16223957
[TBL] [Abstract][Full Text] [Related]
7. BYK191023 (2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3h-imidazo[4,5-b]pyridine) is an NADPH- and time-dependent irreversible inhibitor of inducible nitric-oxide synthase.
Tiso M; Strub A; Hesslinger C; Kenney CT; Boer R; Stuehr DJ
Mol Pharmacol; 2008 Apr; 73(4):1244-53. PubMed ID: 18178668
[TBL] [Abstract][Full Text] [Related]
8. KLYP956 is a non-imidazole-based orally active inhibitor of nitric-oxide synthase dimerization.
Symons KT; Massari ME; Nguyen PM; Lee TT; Roppe J; Bonnefous C; Payne JE; Smith ND; Noble SA; Sablad M; Rozenkrants N; Zhang Y; Rao TS; Shiau AK; Hassig CA
Mol Pharmacol; 2009 Jul; 76(1):153-62. PubMed ID: 19364813
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationship of a new series of COX-2 selective inhibitors: 1,5-diarylimidazoles.
Almansa C; Alfón J; de Arriba AF; Cavalcanti FL; Escamilla I; Gómez LA; Miralles A; Soliva R; Bartrolí J; Carceller E; Merlos M; García-Rafanell J
J Med Chem; 2003 Jul; 46(16):3463-75. PubMed ID: 12877584
[TBL] [Abstract][Full Text] [Related]
10. Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS dimerization inhibitors that are orally active in pain models.
Payne JE; Bonnefous C; Symons KT; Nguyen PM; Sablad M; Rozenkrants N; Zhang Y; Wang L; Yazdani N; Shiau AK; Noble SA; Rix P; Rao TS; Hassig CA; Smith ND
J Med Chem; 2010 Nov; 53(21):7739-55. PubMed ID: 20931971
[TBL] [Abstract][Full Text] [Related]
11. Discovery of inducible nitric oxide synthase (iNOS) inhibitor development candidate KD7332, part 1: Identification of a novel, potent, and selective series of quinolinone iNOS dimerization inhibitors that are orally active in rodent pain models.
Bonnefous C; Payne JE; Roppe J; Zhuang H; Chen X; Symons KT; Nguyen PM; Sablad M; Rozenkrants N; Zhang Y; Wang L; Severance D; Walsh JP; Yazdani N; Shiau AK; Noble SA; Rix P; Rao TS; Hassig CA; Smith ND
J Med Chem; 2009 May; 52(9):3047-62. PubMed ID: 19374401
[TBL] [Abstract][Full Text] [Related]
12. The rational design of inhibitors of nitric oxide formation by inducible nitric oxide synthase.
Whitlow M; Adler M; Davey D; Huang Q; Koovakkat S; Parkinson JF; Pham E; Polokoff M; Xu W; Yuan S; Phillips G
Bioorg Med Chem Lett; 2007 May; 17(9):2505-8. PubMed ID: 17336523
[TBL] [Abstract][Full Text] [Related]
13. Novel 6-methanesulfonamide-3,4-methylenedioxyphenyl-N-acylhydrazones: orally effective anti-inflammatory drug candidates.
Tributino JL; Duarte CD; Corrêa RS; Doriguetto AC; Ellena J; Romeiro NC; Castro NG; Miranda AL; Barreiro EJ; Fraga CA
Bioorg Med Chem; 2009 Feb; 17(3):1125-31. PubMed ID: 19135376
[TBL] [Abstract][Full Text] [Related]
14. Optimization of a potent class of arylamide colony-stimulating factor-1 receptor inhibitors leading to anti-inflammatory clinical candidate 4-cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[(dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide (JNJ-28312141).
Illig CR; Manthey CL; Wall MJ; Meegalla SK; Chen J; Wilson KJ; Ballentine SK; Desjarlais RL; Schubert C; Crysler CS; Chen Y; Molloy CJ; Chaikin MA; Donatelli RR; Yurkow E; Zhou Z; Player MR; Tomczuk BE
J Med Chem; 2011 Nov; 54(22):7860-83. PubMed ID: 22039836
[TBL] [Abstract][Full Text] [Related]
15. In vivo characterization of the novel imidazopyridine BYK191023 [2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine], a potent and highly selective inhibitor of inducible nitric-oxide synthase.
Lehner MD; Marx D; Boer R; Strub A; Hesslinger C; Eltze M; Ulrich WR; Schwoebel F; Schermuly RT; Barsig J
J Pharmacol Exp Ther; 2006 Apr; 317(1):181-7. PubMed ID: 16368897
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of inducible nitric-oxide synthase dimerization inhibition by novel pyrimidine imidazoles.
Nagpal L; Haque MM; Saha A; Mukherjee N; Ghosh A; Ranu BC; Stuehr DJ; Panda K
J Biol Chem; 2013 Jul; 288(27):19685-97. PubMed ID: 23696643
[TBL] [Abstract][Full Text] [Related]
17. Novel nanomolar imidazo[4,5-b]pyridines as selective nitric oxide synthase (iNOS) inhibitors: SAR and structural insights.
Grädler U; Fuchss T; Ulrich WR; Boer R; Strub A; Hesslinger C; Anézo C; Diederichs K; Zaliani A
Bioorg Med Chem Lett; 2011 Jul; 21(14):4228-32. PubMed ID: 21684157
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity.
Martin MW; Newcomb J; Nunes JJ; Boucher C; Chai L; Epstein LF; Faust T; Flores S; Gallant P; Gore A; Gu Y; Hsieh F; Huang X; Kim JL; Middleton S; Morgenstern K; Oliveira-dos-Santos A; Patel VF; Powers D; Rose P; Tudor Y; Turci SM; Welcher AA; Zack D; Zhao H; Zhu L; Zhu X; Ghiron C; Ermann M; Johnston D; Saluste CG
J Med Chem; 2008 Mar; 51(6):1637-48. PubMed ID: 18278858
[TBL] [Abstract][Full Text] [Related]
19. Rational design of non-nucleoside, potent, and orally bioavailable adenosine deaminase inhibitors: predicting enzyme conformational change and metabolism.
Terasaka T; Tsuji K; Kato T; Nakanishi I; Kinoshita T; Kato Y; Kuno M; Inoue T; Tanaka K; Nakamura K
J Med Chem; 2005 Jul; 48(15):4750-3. PubMed ID: 16033254
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of pyrido[1,2-a]pyrimidines as inhibitors of nitric oxide synthases.
Bluhm U; Boucher JL; Buss U; Clement B; Friedrich F; Girreser U; Heber D; Lam T; Lepoivre M; Rostaie-Gerylow M; Wolschendorf U
Eur J Med Chem; 2009 Jul; 44(7):2877-87. PubMed ID: 19144449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
